CREO PRODUCTS INC
6-K, 2000-04-03
PRINTING TRADES MACHINERY & EQUIPMENT
Previous: RAINBOW RENTALS INC, DEF 14A, 2000-04-03
Next: BRISTOL HOTELS & RESORTS, SC TO-T/A, 2000-04-03



                SECURITIES AND EXCHANGE COMMISSION
                      Washington, D.C.  20549

                              FORM 6-K

                      REPORT OF FOREIGN ISSUER
              PURSUANT TO RULA 13a-16 OR 15d-16 OF THE
                  SECURITIES EXCHANGE ACT OF 1934

                           March 31, 2000

                         CREO PRODUCTS INC.
       (Exact name of Registrant as specified in its charter)

                          3700 Gilmore Way
                    Burnaby, B.C. Canada V5G 4M1
              (Address of principal executive offices)

       (Indicate by check mark whether the registrant files or will file
  annual reports under cover Form 20-F or Form 40-F.)

              Form 20-F     x          Form 40-F
                           ---                      ---

       (Indicate by check mark whether the registrant by furnishing the
  information contained in this Form is also thereby furnishing the
  information to the Commission pursuant to Rule 12g3-2(b) under the
  Securities Exchange Act of 1934.)

            Yes            No     x
                  ---            ---

       (If "Yes" is marked, indicate below the file number assigned to the
  registrant in connection with Rule 12g3-2(b): 82- ___.)

  <PAGE>

                          FOR IMMEDIATE RELEASE
         CREO SHAREHOLDERS APPROVE ISSUANCE OF 13.25 MILLION SHARES

  Vancouver, BC, CANADA (March 31, 2000)   Creo Products Inc. (NASDAQ: CREO;
  TSE: CRE) ("Creo") is pleased to announce that shareholders approved the
  issuance of 13.25 million Creo shares in consideration for the assets of
  the digital prepress and print-on-demand businesses of Scitex Corporation
  Ltd. (NASDAQ: SCIX) ("Scitex") of Herzlia, Israel.  The approval was given
  yesterday at the Creo annual general and special meeting and is pursuant
  to a previously announced Asset Purchase Agreement dated January 17, 2000.
  The 13.25 million Creo shares are valued at some US$ 551 million.

  Creo expects to close the transaction the week of April 3, 2000.  The new
  graphic arts group will combine the prepress operations of Scitex and
  Creo, and will operate as a division of Creo under the name "CreoScitex."
  Creo shares will continue to trade under the symbol CREO on NASDAQ and CRE
  on the Toronto Stock Exchange. The combined entity will capitalize on
  strong synergies in technology, products, service, and distribution to
  create a leading provider of worldwide digital prepress solutions.

  Following the closing, Rimon Ben-Shaoul, Chairman of the Scitex board; and
  Yoav Z. Chelouche, President and CEO of Scitex; will be appointed to the
  Creo board. Scitex will own approximately 26.1% of the outstanding Creo
  shares on a fully diluted basis and will enter into a five-year standstill
  agreement that includes, amongst other things, restrictions on acquiring
  additional Creo shares as well as customary transfer, voting, and other
  restrictions. The transaction is being accounted for by Creo as a purchase
  and is expected to be accretive to Creo's earnings per share before
  goodwill in the current fiscal year.

  <PAGE>

  This release contains forward-looking statements within the meaning of the
  "safe harbor" provisions of the U.S. Private Securities Litigation Reform
  Act of 1995, including statements with respect to the anticipated cost
  savings, synergies, and other benefits of the transaction.  These
  statements are based on management's current expectations and beliefs and
  are subject to a number of risks and uncertainties that could cause actual
  results to differ materially from those described in the forward-looking
  statements.

  These risks and uncertainties include the following:  (1) Creo and
  Heidelberger Druckmaschinen A.G. are unable to reach agreement on any
  changes to their current joint-venture agreement, which may be necessary
  in light of the combination Creo's business with the Scitex Business; (2)
  the expected cost-savings and synergies cannot be fully realized or take
  significantly longer to realize than expected; (3) revenues from the
  Scitex Business are lower than expected or customer attrition and business
  disruption following the acquisition are greater than expected;  (4) the
  integration of the Scitex Business into Creo's operations is more
  difficult, time-consuming or expensive than anticipated, or the attrition
  rate of key employees of the combined business is greater than expected;
  (5) technological changes or changes in the competitive environment
  adversely affect the products, market share, revenues or margins of the
  combined business; or (6) changes in general economic, financial or
  business conditions adversely affect the combined business or the markets
  in which it operates.

  Creo and the Creo logo are registered trademarks of Creo Products Inc.
  Other products may be the trademarks of their respective companies.

                            -###-




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission